Gatifloxacin Ophthalmic

283 interactions 389 cited references
Also sold as: Zymar® Zymaxid Zymaxid®
About Gatifloxacin Ophthalmic

Gatifloxacin ophthalmic solution is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids) in adults and children 1 year of age and older. Gatifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the… Read the full Gatifloxacin Ophthalmic drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dronedarone Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir
12 Contraindicated 254 Major 17 Moderate
All (283) Contraindicated (12) Major (254) Moderate (17)

Major

Gatifloxacin Ophthalmic Bupropion Aplenzin Increased risk of seizures Details Gatifloxacin Ophthalmic Canagliflozin Invokana Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Ceritinib Zykadia An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Chloroquine Aralen® An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Chlorpromazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Chlorpropamide Diabinese® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Cholera Vaccine, Live Reduced immune response to the cholera vaccine Details Gatifloxacin Ophthalmic Ciprofloxacin An increased risk of fluoroquinolones-related adverse reactions and an increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Citalopram Celexa An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Clarithromycin Biaxin An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Clofazimine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Clomipramine Anafranil An increased risk of QT interval prolongation and an increased risk of seizures Details Gatifloxacin Ophthalmic Clothiapine Increased risk of cardiac arrhythmias Details Gatifloxacin Ophthalmic Clozapine Clozaril Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Corticotropin An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Cortisone An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Cosyntropin An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Crizotinib Xalkori An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Cyclobenzaprine Amrix An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Dabrafenib Tafinlar An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Dapagliflozin Farxiga Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Dasatinib Phyrago An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Deflazacort Emflaza An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Degarelix Firmagon Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Delamanid Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Desflurane Suprane An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Desipramine Norpramin An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Dexamethasone An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Dexmedetomidine Dexased Increased risk of cardiac arrhythmias Details Gatifloxacin Ophthalmic Disopyramide Norpace An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Dofetilide Tikosyn An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Dolasetron Anzemet An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Domperidone Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Donepezil Adlarity Increased risk of QT-interval prolongation and torsade de pointes Details Gatifloxacin Ophthalmic Dordaviprone An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Dothiepin An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Doxepin Prudoxin An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Droperidol An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Dulaglutide Trulicity Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.